Markets · 1 sources covering this

Already jumped 55% in 2026, PL Capital sees more returns in Sai Lifesciences shares | Check target, upside

PL Capital believes the company is well positioned to benefit from increasing pharmaceutical outsourcing, a deep commercial pipeline and capacity expansion

Share:WhatsApp X Reddit Facebook

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

MintLean R·1h ago
Already jumped 55% in 2026, PL Capital sees more returns in Sai Lifesciences shares | Check target, upside
PL Capital believes the company is well positioned to benefit from increasing pharmaceutical outsourcing, a deep commercial pipeline and capacity expansion
Read at Mint →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/393cdda19ed68cb6e03318fa92e22e860120a148"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Already jumped 55% in 2026, PL Capital sees more returns in Sai Lifesciences shares | Check target, upside"></iframe>

Already jumped 55% in 2026, PL Capital sees more returns in Sai Lifesciences shares | Check target, upside

How 1 sources are covering this

Already jumped 55% in 2026, PL Capital sees more returns in Sai Lifesciences shares | Check target, upside

More from Markets

D-Street bleeds! Market value of all BSE-listed firms falls below Rs 450 lakh crore for first time since April. More pain ahead?

Why are mid, small-caps bleeding? Indices crash up to 4% - Swiggy, Meesho, Vedanta Aluminium, MCX lose big

Silver prices slide below Rs 2 lakh/kg, down nearly 55% from Jan peak. What’s behind the rapid selloff?

Silver rate today at 11-month low; slips below ₹2 lakh in India — where will it go? Should you buy for good returns?

Reader

Trust & legal

Across the network